| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seer, Inc. | CHIEF LEGAL OFFICER | Class A Common Stock | 273,142 | $431,209 | $1.58 | 22 Feb 2024 | Direct |
| Seer, Inc. | CHIEF LEGAL OFFICER | Employee Stock Option (right to buy) | 140,000 | 06 Feb 2024 | Direct | ||
| Apimeds Pharmaceuticals US, Inc. | Director | Stock Option (right to buy) | 10,000 | 11 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APUS | Apimeds Pharmaceuticals US, Inc. | 11 Nov 2025 | 1 | $0 | 4 | Director | 13 Nov 2025, 18:28 |
| APUS | Apimeds Pharmaceuticals US, Inc. | 15 Oct 2025 | 1 | $0 | 4 | Director | 24 Oct 2025, 16:35 |
| APUS | Apimeds Pharmaceuticals US, Inc. | 16 May 2025 | 1 | $0 | 4 | Director | 20 May 2025, 17:18 |
| APUS | Apimeds Pharmaceuticals US, Inc. | 04 Mar 2025 | 0 | $0 | 3 | Director | 08 May 2025, 17:37 |
| SEER | Seer, Inc. | 06 Feb 2024 | 4 | -$20,024 | 4 | CHIEF LEGAL OFFICER | 23 Feb 2024, 17:32 |
| SEER | Seer, Inc. | 04 Dec 2023 | 1 | -$13,869 | 4 | Chief Legal Officer | 06 Dec 2023, 16:43 |
| SEER | Seer, Inc. | 21 Feb 2023 | 1 | -$24,603 | 4 | General Counsel and Secretary | 22 Feb 2023, 18:09 |
| SEER | Seer, Inc. | 15 Feb 2023 | 2 | $0 | 4 | General Counsel and Secretary | 17 Feb 2023, 18:53 |
| SEER | Seer, Inc. | 08 Jun 2022 | 1 | -$72,923 | 4 | General Counsel and Secretary | 10 Jun 2022, 20:17 |
| SEER | Seer, Inc. | 08 Feb 2022 | 2 | $0 | 4 | General Counsel and Secretary | 10 Feb 2022, 18:13 |